IMVT Stock Analysis: Buy, Sell, or Hold?
IMVT - Immunovant, Inc. Common Stock
$38.62
-0.86 (-2.18%)
▼
5d:
-2.0%
30d:
+1.26%
90d:
+42.27%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
2d
Get Alerted When IMVT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: IMVT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: IMVT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: IMVT is currently trading at $38.62, which is considered slightly low relative to its 30-day fair value range of $38.30 to $39.94.
Technical Outlook: Technically, IMVT is in a strong uptrend. The price is currently testing key support at $37.75. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $46.88 (+21.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IMVT is in a strong uptrend. The price is currently testing key support at $37.75. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $46.88 (+21.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$38.30 -
$39.94
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.4% below Wall St target ($46.88)
Trading Range Analysis
30-Day Trading Range
$38.30 -
$39.94
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$37.75
Resistance Level
$41.21
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.95
Wall Street Target
$46.88
(+21.4%)
Share & Embed Analysis
Last updated: August 02, 2026 8:09 PM ET
Data refreshes hourly during market hours. Next update: 9:09 PM
Data refreshes hourly during market hours. Next update: 9:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMVT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Tiago Girao
SELL
25760 shares
2026-04-23
Jay S Stout
SELL
2754 shares
2026-04-23
Jay S Stout
SELL
10132 shares
2026-04-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 50 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$834 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$267 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 56 HOLD |
Advanced IMVT Option Strategies
Professional options setups generated by AI based on today's IMVT price and gamma walls.
